MiddleBrook Pharmaceuticals, Inc. (NASDAQ: MBRK)

MiddleBrook Pharmaceuticals, Inc. (NASDAQ: MBRK), a pharmaceutical company, is focused on developing and commercializing anti-infective drug products that address unmet medical needs in anti-infective therapy. The company’s aim is to develop a portfolio of drugs based on their biological finding that bacteria are killed more efficiently and effectively when exposed to antibiotics in front-loaded, sequential bursts, or pulses, than those exposed to standard antibiotic treatment regimens. For further information, visit the Company’s web site at www.middlebrookpharma.com.